Tyrosine kinase
From Proteopedia
Line 287: | Line 287: | ||
*'''CapAB tyrosine kinase''' | *'''CapAB tyrosine kinase''' | ||
- | [[3bfv]] - SaTK CapA1/CapB2 – ''Staphylococcus aureus'' <br /> | + | **[[3bfv]] - SaTK CapA1/CapB2 – ''Staphylococcus aureus'' <br /> |
- | [[2ved]] - SaTK CapA1/CapB2 + Mg + ADP | + | **[[2ved]] - SaTK CapA1/CapB2 + Mg + ADP |
- | + | *'''Fer tyrosine kinase''' | |
- | [[2kk6]] - hTK Fer SH2 domain – NMR<BR /> | + | **[[2kk6]] - hTK Fer SH2 domain – NMR<BR /> |
- | + | *'''Ptk6 tyrosine kinase''' | |
- | [[1rja]] - hTK Ptk6 SH2 domain – NMR<br /> | + | **[[1rja]] - hTK Ptk6 SH2 domain – NMR<br /> |
- | [[2kgt]] - hTK Ptk6 SH3 domain – NMR<br /> | + | **[[2kgt]] - hTK Ptk6 SH3 domain – NMR<br /> |
- | + | *'''Lyn tyrosine kinase''' | |
- | [[1w1f]] - hTK Lyn SH3 domain – NMR<br /> | + | **[[1w1f]] - hTK Lyn SH3 domain – NMR<br /> |
- | [[1wa7]] - hTK Lyn SH3 domain + peptide – NMR<br /> | + | **[[1wa7]] - hTK Lyn SH3 domain + peptide – NMR<br /> |
- | [[3a4o]] - hTK Lyn residues 233-512 + staurosporine<br /> | + | **[[3a4o]] - hTK Lyn residues 233-512 + staurosporine<br /> |
- | [[2zv7]] - mTK Lyn kinase domain<br /> | + | **[[2zv7]] - mTK Lyn kinase domain<br /> |
- | [[2zv8]] - mTK Lyn kinase domain + AMPPNP<br /> | + | **[[2zv8]] - mTK Lyn kinase domain + AMPPNP<br /> |
- | [[2zv9]] - mTK Lyn kinase domain + PP2<br /> | + | **[[2zv9]] - mTK Lyn kinase domain + PP2<br /> |
- | [[2zva]] - mTK Lyn kinase domain + cancer drug<br /> | + | **[[2zva]] - mTK Lyn kinase domain + cancer drug<br /> |
- | + | *'''Txk tyrosine kinase''' | |
- | [[2dm0]] - hTK Txk SH2 domain – NMR<br /> | + | **[[2dm0]] - hTK Txk SH2 domain – NMR<br /> |
- | + | *'''Yes tyrosine kinase''' | |
- | [[2hda]] - hTK Yes SH3 domain <br /> | + | **[[2hda]] - hTK Yes SH3 domain <br /> |
- | + | *'''Tec tyrosine kinase''' | |
- | [[2lul]] - hTK Tec PH domain - NMR<br /> | + | **[[2lul]] - hTK Tec PH domain - NMR<br /> |
- | + | *'''Fes/Fps tyrosine kinase''' | |
- | [[1wqu]], [[2dcr]] - hTK Fes SH2 domain - NMR<br /> | + | **[[1wqu]], [[2dcr]] - hTK Fes SH2 domain - NMR<br /> |
- | [[3bkb]] - hTK Fes SH2+kinase domain - NMR<br /> | + | **[[3bkb]] - hTK Fes SH2+kinase domain - NMR<br /> |
- | [[4dyl]] - hTK Fes F-Bar domain <br /> | + | **[[4dyl]] - hTK Fes F-Bar domain <br /> |
- | [[3cbl]] - hTK Fes SH2+kinase domain + peptide<br /> | + | **[[3cbl]] - hTK Fes SH2+kinase domain + peptide<br /> |
- | [[3cd3]] - hTK Fes SH2+kinase domain + peptide + staurosporine<br /> | + | **[[3cd3]] - hTK Fes SH2+kinase domain + peptide + staurosporine<br /> |
- | [[4e93]] - hTK TFes + inhibitor<br /> | + | **[[4e93]] - hTK TFes + inhibitor<br /> |
- | + | *'''Etk tyrosine kinase''' | |
- | [[3cio]] - EcTK Etk kinase domain – Escherichia coli<br /> | + | **[[3cio]] - EcTK Etk kinase domain – Escherichia coli<br /> |
- | + | *'''Wzc tyrosine kinase''' | |
- | [[3la6]] - EcTK Wzc kinase domain <br /> | + | **[[3la6]] - EcTK Wzc kinase domain <br /> |
- | + | *'''Ros tyrosine kinase''' | |
- | [[3zbf]] - hTK Ros kinase domain + cancer drug<br /> | + | **[[3zbf]] - hTK Ros kinase domain + cancer drug<br /> |
- | + | *'''Tyk tyrosine kinase''' | |
- | [[3lxn]], [[3lxp]], [[3nyx]], [[3nz0]], [[4e1z]], [[4e20]], [[4gfo]], [[4gih]], [[4gii]], [[4gj2]], [[4gj3]] - hTK Tyk2 kinase domain (mutant) + inhibitor<br /> | + | **[[3lxn]], [[3lxp]], [[3nyx]], [[3nz0]], [[4e1z]], [[4e20]], [[4gfo]], [[4gih]], [[4gii]], [[4gj2]], [[4gj3]] - hTK Tyk2 kinase domain (mutant) + inhibitor<br /> |
- | [[4gvj]] - hTK Tyk2 kinase domain (mutant) + ADP<br /> | + | **[[4gvj]] - hTK Tyk2 kinase domain (mutant) + ADP<br /> |
- | [[4po6]] - hTK Tyk2 SH2+FERM domains + IFNAR1 peptide<br /> | + | **[[4po6]] - hTK Tyk2 SH2+FERM domains + IFNAR1 peptide<br /> |
- | + | *'''Kit tyrosine kinase''' | |
- | [[2ec8]] - hNTPK Kit extracellular domain<br /> | + | **[[2ec8]] - hNTPK Kit extracellular domain<br /> |
- | [[3g0e]], [[3g0f]] - hNTPK Kit kinase domain (mutant) + cancer drug<br /> | + | **[[3g0e]], [[3g0f]] - hNTPK Kit kinase domain (mutant) + cancer drug<br /> |
- | [[2e9w]], [[2o26]] - hNTPK Kit extracellular domain + stem cell factor<br /> | + | **[[2e9w]], [[2o26]] - hNTPK Kit extracellular domain + stem cell factor<br /> |
- | + | *'''Hck tyrosine kinase''' | |
- | [[3hck]] - hTK SH2 domain - NMR<BR /> | + | **[[3hck]] - hTK SH2 domain - NMR<BR /> |
- | [[1bu1]] - hTK SH3 domain <BR /> | + | **[[1bu1]] - hTK SH3 domain <BR /> |
- | [[4hck]], [[5hck]] - hTK SH3 domain - NMR<BR /> | + | **[[4hck]], [[5hck]] - hTK SH3 domain - NMR<BR /> |
- | [[2oj2]], [[2oi3]] - hTK SH3 domain + peptide - NMR<BR /> | + | **[[2oj2]], [[2oi3]] - hTK SH3 domain + peptide - NMR<BR /> |
- | [[3rbb]], [[3rea]], [[3reb]] - hTK SH3 domain (mutant) + HIV NEF<BR /> | + | **[[3rbb]], [[3rea]], [[3reb]] - hTK SH3 domain (mutant) + HIV NEF<BR /> |
- | [[3nhn]] - hTK SH3-SH2-linker domain <BR /> | + | **[[3nhn]] - hTK SH3-SH2-linker domain <BR /> |
- | [[2c0i]], [[2c0o]], [[2c0t]] - hTK SH3-SH2-SH1 domain + inhibitor<BR /> | + | **[[2c0i]], [[2c0o]], [[2c0t]] - hTK SH3-SH2-SH1 domain + inhibitor<BR /> |
- | [[2hk5]] - hTK kinase domain + inhibitor<BR /> | + | **[[2hk5]] - hTK kinase domain + inhibitor<BR /> |
- | [[1qcf]], [[3vry]], [[3vrz]], [[3vs0]], [[3vs1]], [[3vs2]], [[3vs3]], [[3vs4]], [[3vs5]], [[3vs6]], [[3vs7]] - hTK SH3-SH2-kinase-tail domain + inhibitor<BR /> | + | **[[1qcf]], [[3vry]], [[3vrz]], [[3vs0]], [[3vs1]], [[3vs2]], [[3vs3]], [[3vs4]], [[3vs5]], [[3vs6]], [[3vs7]] - hTK SH3-SH2-kinase-tail domain + inhibitor<BR /> |
- | [[1ad5]] - hTK SH3-SH2-kinase-tail domain + AMPPNP<BR /> | + | **[[1ad5]] - hTK SH3-SH2-kinase-tail domain + AMPPNP<BR /> |
- | [[2hck]] - hTK SH3-SH2-kinase-tail domain + quercetin<BR /> | + | **[[2hck]] - hTK SH3-SH2-kinase-tail domain + quercetin<BR /> |
- | [[4lud]], [[4lue]] - hTK Hck SH2+SH3+kinase domain (mutant) + fluorescent compound<br /> | + | **[[4lud]], [[4lue]] - hTK Hck SH2+SH3+kinase domain (mutant) + fluorescent compound<br /> |
- | [[4orz]] - hTK Hck SH3 domain (mutant) + NEF + single domain antibody<br /> | + | **[[4orz]] - hTK Hck SH3 domain (mutant) + NEF + single domain antibody<br /> |
- | ===Receptor tyrosine kinases - RTK=== | + | *===Receptor tyrosine kinases - RTK=== |
- | + | *'''Bruton’s tyrosine kinase''' | |
- | [[2z0p]] - hTK Btk PH domain<br /> | + | **[[2z0p]] - hTK Btk PH domain<br /> |
- | [[1btk]] – hTK Btk PH domain (mutant) <br /> | + | **[[1btk]] – hTK Btk PH domain (mutant) <br /> |
- | [[3p08]], [[1k2p]] - hTK Btk kinase domain<br /> | + | **[[3p08]], [[1k2p]] - hTK Btk kinase domain<br /> |
- | [[1aww]], [[1awx]], [[1qly]] - hTK Btk SH3 domain – NMR<BR /> | + | **[[1aww]], [[1awx]], [[1qly]] - hTK Btk SH3 domain – NMR<BR /> |
- | [[2ge9]] - hTK Btk SH2 domain – NMR<BR /> | + | **[[2ge9]] - hTK Btk SH2 domain – NMR<BR /> |
''Btk complex'' | ''Btk complex'' |
Revision as of 07:58, 16 December 2014
|
Contents |
3D structures of tyrosine kinase
Updated on 16-December-2014 {{#tree:id=OrganizedByTopic|openlevels=0|
- Non-receptor tyrosine kinases - nRTK
- Fyn tyrosine kinase
- Fyn complex
- 1fyn - hTK Fyn SH3 domain + peptide
- 1nyf, 1nyg - hTK Fyn SH3 domain + peptide – NMR
- 1efn, 1avz - hTK Fyn SH3 domain + HIV Nef protein
- 1m27 - hTK Fyn SH3 domain + SH2 domain protein 1A + SLAM peptide
- 4d8d - hTK Fyn SH3 domain (mutant) + HIV Nef protein
- 3ua7 – hTK Fyn SH3 domain + hepatitis virus peptide
- 4eik - hTK Fyn SH3 domain + VSL12 peptide
- 1aot, 1aou - hTK Fyn SH2 domain + phosphopeptide - NMR
- 2dq7 – hTK kinase domain + staurosporine
- 1fyn - hTK Fyn SH3 domain + peptide
- Abelson tyrosine kinase
- Abl1 SH2 domain residues 120-220
- Abl1 SH3 domain residues 60-121
- 1ju5 - hTK SH3 domain (mutant) + CRK SH2 domain + phosphopeptide - NMR
- 1awo - hTK SH3 domain + phosphopeptide – NMR
- 1bbz - hTK SH3 domain + peptide
- 2o88 - hTK SH3 domain (mutant} + peptide
- 1abo - mTK SH3 domain + peptide
- 1abq - mTK SH3 domain
- 4jjb, 4jjc, 4jjd - hTK abl SH3 domain
- 4j9b, 3egu, 3eg2, 3eg3, 3eg0, 3eg1 - hTK abl SH3 domain (mutant)
- 4j9c, 4j9e, 4j9i - hTK abl SH3 domain (mutant) + p17 peptide
- 4j9d, 4j9f - hTK abl SH3 domain (mutant) + p0 peptide
- 4j9g, 4j9h - hTK abl SH3 domain (mutant) + p7 peptide
- 1ju5 - hTK SH3 domain (mutant) + CRK SH2 domain + phosphopeptide - NMR
- Abl1 SH3-SH2 domain
- Abl1 kinase domain residues 229-512
- 2g2h - hTK kinase domain (mutant)
- 1opj, 1opk - mTK kinase domain
- 2g2i, 2g2f - hTK kinase domain (mutant) + peptide
- 3ue4, 3cs9, 2hzi, 2hz4, 2hz0, 2hyy, 2gqg - hTK kinase domain + cancer drug
- 2f4j - hTK kinase domain (mutant) + cancer drug
- 3qrk, 3qri, 3qrj, 2v7a, 2e2b, 2hiw - hTK kinase domain + inhibitor
- 1fpu, 1m52, 2qoh, 3kf4, 3kfa - mTK kinase domain + inhibitor
- 2z60, 3dk3, 3dk6, 3dk7 - mTK kinase domain (mutant) + inhibitor
- 1iep, 2hzn, 3k5v, 3ms9, 3mss, 3oxz - mTK kinase domain + cancer drug
- 3ik3, 3oy3 - mTK kinase domain (mutant) + cancer drug
- 2g2h - hTK kinase domain (mutant)
- Abl1 SH3-SH2-kinase domain
- 1opl - hTK SH3-SH2-kinase domain (mutant}
- 1opl - hTK SH3-SH2-kinase domain (mutant}
- Abl1 F-actin binding domain residues 1007-1130
- 1zzp - hTK abl F-actin binding domain – NMR
- 1zzp - hTK abl F-actin binding domain – NMR
- Abl2 SH2 domain residues 165-273
- Abl2 kinase domain residues 279-546
- Abl2 C-terminal residues 1058-1182
- 2kk1 – hTK C terminal – NMR
- 2kk1 – hTK C terminal – NMR
- Anaplastic lymphoma kinase (Alk)
- 2xb7, 2xba, 3aox - hTK kinase domain + inhibitor
- 4dce, 4fob, 4foc, 4fod, 4fny, 4fnz, 4joa - hTK kinase domain (mutant) + inhibitor
- 2xp2 - hTK kinase domain + cancer drug
- 2yfx, 4anq, 4ans - hTK kinase domain (mutant) + cancer drug
- 3l9p, 3lcs, 3lct, 2yhv, 2yjr, 2yjs, 4fnw, 4fnx, 4anl - hTK kinase domain (mutant)
- 2xb7, 2xba, 3aox - hTK kinase domain + inhibitor
- Csk tyrosine kinase
- Jak tyrosine kinase see Janus kinase
- p55-blk tyrosine kinase
- Src tyrosine kinase
- Src tyrosine kinase SH2 domain
- 3eac - hTK
- 4f59, 3eaz - hTK (mutant)
- 1f2f - cTK (mutant)
- 1spr - RsvTK + phosphate – Rous sarcoma virus
- 1kc2, 1sps - RsvTK + peptide
- 1sha, 1shb - RsvTK + phosphopeptide
- 1shd - cTK + TRKA receptor
- 4f5b - hTK (mutant) + phosphotyrosine
- 4f5a - hTK (mutant) + phosphate
- 1o4c - hTK + phosphate
- 1o41, 1o42, 1o43, 1o44, 1o45, 1o46, 1o47, 1o48, 1o49, 1o4a, 1o4b, 1o4d, 1o4e, 1o4f, 1o4g, 1o4h, 1o4i, 1o4j, 1o4k, 1o4l, 1o4m, 1o4n, 1o4o, 1o4p, 1o4q, 1o4r - hTK + inhibitor
- 1hcs, 1hct - hTK + peptide - NMR
- 1a07, 1a08, 1a09, 1a1a, 1a1b, 1a1c, 1a1e - hTK + peptide
- 1f1w - cTK (mutant) + peptide
- 1p13 - cTK + peptide
- 3eac - hTK
- Src tyrosine kinase SH3 domain
- Src tyrosine kinase kinase domain residues 253-535
- 3of0, 2qi8 - cTK (mutant)
- 1yoj - hTK (mutant)
- 3tz7, 3tz8, 3tz9, 4dgg – cTK (mutant) + pyrazolin derivative
- 4fic, 3uqg, 3uqf, 3u51, 3u4w, 4agw, 3qlg, 3qlf, 3g6g, 3el8, 3f6x, 2hwo, 2hwp, 2oiq, 3en4, 3en5, 3en6, 3en7, 3el7 – cTK + inhibitor
- 4lgg, 4lgh, 3svv, 3oez, 3lok, 3g5d, 3f3w, 3f3v, 3geq, 3g6h, 3f3t, 3f3u, 2qlq, 2qq7, 4lgg, 4lgh – cTK (mutant) + inhibitor
- 1yol, 1yom – hTK (mutant) + inhibitor
- 2bdf, 2bdj – hTK + inhibitor
- 1byg – hTK + staurosporine
- 4mxo – hTK + cancer drug
- 4mxx, 4mxy, 4mxz – hTK (mutant) + cancer drug
- 3d7t, 3d7u – cTK + Csk
- 3dqw, 3dqx - cTK (mutant) + ATP
- 3of0, 2qi8 - cTK (mutant)
- Src tyrosine kinase C terminal domain
- Src tyrosine kinase SH2+SH3+kinase domains residues 85-535
- Src tyrosine kinase SH2+SH3+kinase+C terminal domains
- Src tyrosine kinase N terminal+SH2+SH3+kinase domains
- 2h8h – hTK + inhibitor
- 2h8h – hTK + inhibitor
- Lymphocyte-specific tyrosine kinase Lck
- Lck complex
- 1lcj, 1lkk, 1lkl - hTK Lck SH2 domain (mutant) + phosphopeptide
- 1cwd, 1cwe, 1ijr - hTK Lck SH2 domain + phosphopeptide
- 1bhf - hTK Lck SH2 domain + peptide inhibitor
- 1fbz - hTK Lck SH2 domain + inhibitor
- 1bhh - hTK Lck SH2 domain + T-lymphocyte-specific TK
- 1lck - hTK Lck SH3-SH2 domain (mutant) + phosphopeptide
- 1x27 - hTK Lck SH3-SH2 domain + peptide
- 1qpj - hTK Lck kinase domain + staurosporin
- 2of2, 2of4, 2ofu, 2ofv, 2og8, 3b2w, 3bym, 3bys, 3byu, 2zm1, 2zm4, 3byo, 2zyb, 3ac1, 3ac2, 3ac3, 3ac4, 3ac5, 3ac8, 3acj, 3ack, 3kmm, 3ad4, 3ad5, 3ad6, 1qpc, 1qpd, 1qpe - hTK Lck kinase domain + inhibitor
- 3mpm - hTK Lck kinase domain (mutant) + inhibitor
- 4c3f - hTK Lck kinase domain (mutant) + chemotype
- 2pl0 - hTK Lck kinase domain + imatinib
- 3kxz - hTK Lck kinase domain + probe molecule
- 1q68 - hTK Lck residues 6-34 (mutant) + CD4 peptide – NMR
- 1q69 - hTK Lck residues 6-34 (mutant) + CD8 – NMR
- 1lcj, 1lkk, 1lkl - hTK Lck SH2 domain (mutant) + phosphopeptide
- Syk - spleen tyrosine kinase
- 1xba – Syk kinase domain
- Syk complex
- 1xbb - Syk kinase domain + Gleevec
- 1xbc - Syk kinase domain + staurosporine
- 3emg, 3fqe, 3fqh, 3fqs, 3srv, 4dfl, 4dfn, 3vf8, 3vf9, 3tub, 3tuc, 3tud, 4f4p, 4fyn, 4fyo, 4fz6, 4fz7, 4gfg, 4i0r, 4i0s, 4i0t, 4puz, 4pv0 - Syk kinase domain + inhibitor
- 4px6 - Syk kinase domain (mutant) + inhibitor
- 1csy, 1csz - Syk SH2 domain + phosphopeptide – NMR
- 4fl1, 4fl2 - Syk kinase domain + ANP
- 4fl3 - Syk kinase domain (mutant) + ANP
- 1a81 – Syk tandem SH2 domain + T-cell surface peptide
- 1xbb - Syk kinase domain + Gleevec
- Itk tyrosine kinase
- 1lui, 1luk, 1lum, 1lun – mTK Itk SH2 domain – NMR
- 3s9k – mTK Itk SH2 domain
- 2etz, 2eu0 – hTK Itk SH2 domain + phosphopeptide – NMR
- 1awj, 2rn8, 2rna – mTK Itk SH3 domain – NMR
- 2yuq, 2lmj – hTK Itk SH3 domain – NMR
- 2k79, 2k7a – mTK Itk SH2+SH3 domains – NMR
- 1sm2, 1snu, 1snx – hTK Itk kinase domain
- 3miy – hTK Itk kinase domain + cancer drug
- 3v5j, 3v5l, 3v8t, 3v8w – hTK Itk kinase domain + inhibitor
- 3mj1, 3mj2, 3qgw, 3qgy, 4hct, 4hcu, 4hcv, 4kio – hTK Itk kinase domain (mutant) + inhibitor
- 3t9t – hTK Itk kinase domain (mutant) + arthritis drug
- 2e6i – hTK Itk BTK motif – NMR
- 4l7s, 4m0y, 4m0z, 4m12, 4m13, 4m14, 4m15, 4mf0, 4mf1 - hTK Itk kinase domain + inhibitor
- 1lui, 1luk, 1lum, 1lun – mTK Itk SH2 domain – NMR
- Zap tyrosine kinase
- Zap complex
- Pyk2 tyrosine kinase
- Pyk2 complex
- 3fzp - hTK Pyk2 kinase domain + ATPγS
- 3fzr, 3fzs, 3fzt, 3h3c, 3et7 - hTK Pyk2 kinase domain + inhibitor
- 3gm1 - hTK Pyk2 FAT domain + paxillin peptide
- 4h1j - hFAK2 kinase domain + pyrazole inhibitor
- 4h1m - hFAK2 kinase domain + indole inhibitor
- 3u3c, 3u3f – hFAK2 FAT domain (mutant) + paxillin LD2 motif
- 3fzp - hTK Pyk2 kinase domain + ATPγS
- CapAB tyrosine kinase
- Fer tyrosine kinase
- 2kk6 - hTK Fer SH2 domain – NMR
- 2kk6 - hTK Fer SH2 domain – NMR
- Ptk6 tyrosine kinase
- Lyn tyrosine kinase
- Txk tyrosine kinase
- 2dm0 - hTK Txk SH2 domain – NMR
- 2dm0 - hTK Txk SH2 domain – NMR
- Yes tyrosine kinase
- 2hda - hTK Yes SH3 domain
- 2hda - hTK Yes SH3 domain
- Tec tyrosine kinase
- 2lul - hTK Tec PH domain - NMR
- 2lul - hTK Tec PH domain - NMR
- Fes/Fps tyrosine kinase
- Etk tyrosine kinase
- 3cio - EcTK Etk kinase domain – Escherichia coli
- 3cio - EcTK Etk kinase domain – Escherichia coli
- Wzc tyrosine kinase
- 3la6 - EcTK Wzc kinase domain
- 3la6 - EcTK Wzc kinase domain
- Ros tyrosine kinase
- 3zbf - hTK Ros kinase domain + cancer drug
- 3zbf - hTK Ros kinase domain + cancer drug
- Tyk tyrosine kinase
- Kit tyrosine kinase
- Hck tyrosine kinase
- 3hck - hTK SH2 domain - NMR
- 1bu1 - hTK SH3 domain
- 4hck, 5hck - hTK SH3 domain - NMR
- 2oj2, 2oi3 - hTK SH3 domain + peptide - NMR
- 3rbb, 3rea, 3reb - hTK SH3 domain (mutant) + HIV NEF
- 3nhn - hTK SH3-SH2-linker domain
- 2c0i, 2c0o, 2c0t - hTK SH3-SH2-SH1 domain + inhibitor
- 2hk5 - hTK kinase domain + inhibitor
- 1qcf, 3vry, 3vrz, 3vs0, 3vs1, 3vs2, 3vs3, 3vs4, 3vs5, 3vs6, 3vs7 - hTK SH3-SH2-kinase-tail domain + inhibitor
- 1ad5 - hTK SH3-SH2-kinase-tail domain + AMPPNP
- 2hck - hTK SH3-SH2-kinase-tail domain + quercetin
- 4lud, 4lue - hTK Hck SH2+SH3+kinase domain (mutant) + fluorescent compound
- 4orz - hTK Hck SH3 domain (mutant) + NEF + single domain antibody
- 3hck - hTK SH2 domain - NMR
- ===Receptor tyrosine kinases - RTK===
- Bruton’s tyrosine kinase
Btk complex
1b55 - hTK Btk PH domain + inositol-tetrakisphosphate
1bwn - hTK Btk PH domain (mutant) + inositol-tetrakisphosphate
3gen, 3ocs, 3pix, 3piy, 3piz, 3pj1, 3pj2, 3pj3, 4nwm - hTK Btk kinase domain + inhibitor
3k54, 3t9t, 4ot5, 4ot6, 4otq, 4otr - hTK Btk kinase domain (mutant) + inhibitor
3oct - hTK Btk kinase domain (mutant) + cancer drug
Fms tyrosine kinase
2i0v - hTK Fms kinase domain
Fms complex
2i0y, 2i1m - hTK Fms kinase domain + inhibitor
3dpk - hTK Fms kinase domain (mutant) + inhibitor
1flt – hTK Fms Igg-like domain + VEGF
1qty - hTK Fms domain 2 + VEGF
Mer tyrosine kinase
2dbj - hTK Mer FN2 domain – NMR
2p0c - hTK Mer kinase domain
Mer complex
3brb - hTK Mer kinase domain + ADP
3bpr, 3tcp, 4m3q, 4mh7, 4mha - hTK Mer kinase domain + inhibitor
Bone marrow tyrosine kinase
2ekx - hTK Bmx SH2 domain – NMR
2ys2 - hTK Bmx Btk motif – NMR
Bmx complex
3sxr - hTK Bmx kinase domain (mutant) + dasatinib
3sxs - hTK Bmx kinase domain (mutant) + inhibitor
ErbB tyrosine kinase
See Epidermal Growth Factor Receptor
Musk tyrosine kinase
3hkl - rTK Musk Fz-Crd domain
- ↑ Tou WI, Chen CY. Traditional Chinese medicine as dual guardians against hypertension and cancer? J Biomol Struct Dyn. 2012 Jul;30(3):299-317. Epub 2012 Jun 12. PMID:22694277 doi:10.1080/07391102.2012.680030